224 related articles for article (PubMed ID: 17999117)
1. Global stability of equilibria in a two-sex HPV vaccination model.
Elbasha EH
Bull Math Biol; 2008 Apr; 70(3):894-909. PubMed ID: 17999117
[TBL] [Abstract][Full Text] [Related]
2. Analysis of risk-structured vaccination model for the dynamics of oncogenic and warts-causing HPV types.
Alsaleh AA; Gumel AB
Bull Math Biol; 2014 Jul; 76(7):1670-726. PubMed ID: 25033777
[TBL] [Abstract][Full Text] [Related]
3. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
Dunne EF; Datta SD; E Markowitz L
Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
[TBL] [Abstract][Full Text] [Related]
4. Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review.
Ault KA
Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S26-31. PubMed ID: 16729901
[TBL] [Abstract][Full Text] [Related]
5. Protecting our patients from HPV and HPV-related diseases: the role of vaccines.
Mahoney MC
J Fam Pract; 2006 Nov; Suppl():10-7. PubMed ID: 17366753
[TBL] [Abstract][Full Text] [Related]
6. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
[TBL] [Abstract][Full Text] [Related]
7. Decreasing risk: impact of HPV vaccination on outcomes.
Hymel PA
Am J Manag Care; 2006 Dec; 12(17 Suppl):S473-83. PubMed ID: 17203991
[TBL] [Abstract][Full Text] [Related]
8. Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease.
Dasbach EJ; Elbasha EH; Insinga RP
Epidemiol Rev; 2006; 28():88-100. PubMed ID: 16740585
[TBL] [Abstract][Full Text] [Related]
9. [HPV vaccination: principles, results and future perspectives].
Rouzier R; Uzan C; Collinet P
J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):13-8. PubMed ID: 17293248
[TBL] [Abstract][Full Text] [Related]
10. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.
Pathirana D; Hillemanns P; Petry KU; Becker N; Brockmeyer NH; Erdmann R; Gissmann L; Grundhewer H; Ikenberg H; Kaufmann AM; Klusmann J; Kopp I; Pfister H; Rzany B; Schneede P; Schneider A; Smola S; Winter-Koch N; Wutzler P; Gross G
Vaccine; 2009 Jul; 27(34):4551-9. PubMed ID: 19524337
[TBL] [Abstract][Full Text] [Related]
11. Introducing human papillomavirus vaccines - questions remain.
Paavonen J; Lehtinen M
Ann Med; 2008; 40(3):162-6. PubMed ID: 18382882
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against multiple HPV types.
Elbasha EH; Galvani AP
Math Biosci; 2005 Sep; 197(1):88-117. PubMed ID: 16095627
[TBL] [Abstract][Full Text] [Related]
13. Measuring serum antibody to human papillomavirus following infection or vaccination.
Frazer IH
Gynecol Oncol; 2010 Jun; 118(1 Suppl):S8-11. PubMed ID: 20494221
[TBL] [Abstract][Full Text] [Related]
14. Global implementation of human papillomavirus (HPV) vaccine: lessons from hepatitis B vaccine.
Kane MA
Gynecol Oncol; 2010 May; 117(2 Suppl):S32-5. PubMed ID: 20129654
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus, cervical cancer, and the vaccines.
Tovar JM; Bazaldua OV; Vargas L; Reile E
Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
[TBL] [Abstract][Full Text] [Related]
16. Immunobiology of human papillomavirus infection and vaccination - implications for second generation vaccines.
Stanley M; Gissmann L; Nardelli-Haefliger D
Vaccine; 2008 Aug; 26 Suppl 10():K62-7. PubMed ID: 18847558
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
Paavonen J
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
[TBL] [Abstract][Full Text] [Related]
18. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
[TBL] [Abstract][Full Text] [Related]
19. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
Ault K; Reisinger K
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
[TBL] [Abstract][Full Text] [Related]
20. Preventive and therapeutic HPV vaccines.
Monie A; Hung CF; Wu TC
Curr Opin Investig Drugs; 2007 Dec; 8(12):1038-50. PubMed ID: 18058574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
